We are live on ! Find out more
AIM

AIM ImmunoTech
AIM

14 hedge funds and large institutions have $4.2M invested in AIM ImmunoTech in 2014 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% less funds holding

Funds holding: 16 → 14 (-2)

21% less capital invested

Capital invested by funds: $5.35M → $4.2M (-$1.15M)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
14
Holders Change
-2
Holders Change %
-12.5%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BIT
BlackRock Institutional Trust
California
+$179K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$71.6K
3
Two Sigma Investments
Two Sigma Investments
New York
+$17.9K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$102K
2
Citadel Advisors
Citadel Advisors
Florida
-$71.6K
3
Northern Trust
Northern Trust
Illinois
-$17.9K
4
VKH
Virtu KCG Holdings
New York
-$17.9K
5
WS
Wedbush Securities
California
-$17.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.48M +$71.6K +4 +5%
BIT
2
BlackRock Institutional Trust
California
$1.4M +$179K +10 +13%
OAM
3
Occidental Asset Management
California
$707K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$240K – – –
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$86K – – –
Northern Trust
6
Northern Trust
Illinois
$74K -$17.9K -1 -20%
BTS
7
BB&T Securities
Virginia
$52K – – –
WS
8
Wedbush Securities
California
$35K -$17.9K -1 -33%
State Street
9
State Street
Massachusetts
$28K – – –
GC
10
Guggenheim Capital
Illinois
$25K – – –
Bank of New York Mellon
11
Bank of New York Mellon
New York
$21K – – –
U
12
UBS
Switzerland
$12K – – –
Citadel Advisors
13
Citadel Advisors
Florida
$9K -$71.6K -4 -80%
Bank of America
14
Bank of America
North Carolina
$9K – – –
Two Sigma Investments
15
Two Sigma Investments
New York
$9K +$17.9K +1 New
VKH
16
Virtu KCG Holdings
New York
$5K -$17.9K -1 Closed
JIC
17
Joel Isaacson & Co
New York
$5K – – –
BA
18
BlackRock Advisors
Delaware
$3K – – –
ICAS
19
Investors Capital Advisory Services
Massachusetts
$3K – – –
Wells Fargo
20
Wells Fargo
California
$3K – – –
CHC
21
City Holding Co
West Virginia
$1K – – –
Millennium Management
22
Millennium Management
New York
– -$102K -5 Closed
Citigroup
23
Citigroup
New York
– -$14K -1 Closed

AIM Hedge Fund Activity: Q2 2014 in Review

14 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q2 2014, worth a combined $4.2M — down 21% from $5.35M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of AIM and 1 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was BlackRock Institutional Trust, adding an estimated $179K. The largest seller was Millennium Management, exiting entirely with an estimated $102K sold.

  • 14 institutional investors held AIM ImmunoTech (AIM) as of Q2 2014, down from 16 in Q1 2014.
  • Funds reported $4.2M of AIM ImmunoTech stock for Q2 2014, down 21% quarter-over-quarter.
  • 1 fund opened new AIM ImmunoTech positions in Q2 2014 and 3 closed out, a net change of -2 holders.
  • The largest AIM ImmunoTech buyer in Q2 2014 was BlackRock Institutional Trust, an estimated $179K added.
  • The largest AIM ImmunoTech seller in Q2 2014 was Millennium Management, an estimated $102K sold.

Based on aggregated 13F filings for Q2 2014.